GLAUKOS Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GLAUKOS, and when can generic versions of GLAUKOS drugs launch?
GLAUKOS has two approved drugs.
There are two US patents protecting GLAUKOS drugs.
There are fifty-two patent family members on GLAUKOS drugs in seven countries and eleven supplementary protection certificates in eight countries.
Summary for GLAUKOS
| International Patents: | 52 |
| US Patents: | 2 |
| Tradenames: | 3 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for GLAUKOS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaukos | IDOSE TR | travoprost | IMPLANT;INTRACAMERAL | 218010-001 | Dec 13, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
| Glaukos | PHOTREXA | riboflavin 5'-phosphate | SOLUTION/DROPS;OPHTHALMIC | 203324-001 | Apr 15, 2016 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
| Glaukos | PHOTREXA VISCOUS IN DEXTRAN 20% | riboflavin 5'-phosphate | SOLUTION/DROPS;OPHTHALMIC | 203324-002 | Apr 15, 2016 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
| Glaukos | IDOSE TR | travoprost | IMPLANT;INTRACAMERAL | 218010-001 | Dec 13, 2023 | RX | Yes | Yes | 10,206,813 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Glaukos | IDOSE TR | travoprost | IMPLANT;INTRACAMERAL | 218010-001 | Dec 13, 2023 | RX | Yes | Yes | 11,426,306 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for GLAUKOS Drugs
Supplementary Protection Certificates for GLAUKOS Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1514548 | CA 2014 00038 | Denmark | ⤷ Sign Up | PRODUCT NAME: TRAVOPROST; REG. NO/DATE: EU/1/01/199/001-002 20011127 |
| 1920764 | PA2012017 | Lithuania | ⤷ Sign Up | PRODUCT NAME: TRAVOPROSTUM; NAT. REGISTRATION NO/DATE: LT 02/7821/3 20020402; FIRST REGISTRATION: EU/1/01/199/001 - EU/1/01/199/002 20011127 |
| 1920764 | PA2012017,C1920764 | Lithuania | ⤷ Sign Up | PRODUCT NAME: TRAVOPROSTUM; NAT. REGISTRATION NO/DATE: LT 02/7821/3 20020402; FIRST REGISTRATION: EU/1/01/199/001 - EU/1/01/199/002 20011127 |
| 1920764 | SPC/GB12/038 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: TRAVOPROST; REGISTERED: UK EU/1/01/199/001-002 20011129 |
| 1920764 | C01920764/01 | Switzerland | ⤷ Sign Up | PRODUCT NAME: TRAVOPROST; REGISTRATION NUMBER/DATE: SWISSMEDIC 55910 22.05.2002 |
| 1920764 | 1290027-0 | Sweden | ⤷ Sign Up | PRODUCT NAME: TRAVOPROST |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
